Detalhe da pesquisa
1.
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.
Haematologica
; 108(1): 110-121, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770532
2.
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.
Hematol Oncol
; 41(1): 108-119, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251503
3.
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma.
Ann Hematol
; 102(2): 429-437, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370191
4.
Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
Blood
; 135(13): 996-1007, 2020 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31977002
5.
Neurotoxicity-associated sinus bradycardia after chimeric antigen receptor T-cell therapy.
Hematol Oncol
; 40(3): 482-487, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139240
6.
Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study.
Br J Haematol
; 192(1): 82-99, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32426847
7.
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas.
Haematologica
; 106(2): 513-521, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079701
8.
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy.
Ann Hematol
; 100(9): 2303-2310, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34236497
9.
Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain.
Biol Blood Marrow Transplant
; 26(8): 1534-1542, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068094
10.
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma.
Am J Hematol
; 95(5): 510-520, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32052473
11.
Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia.
Ann Hematol
; 93(1): 43-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24081577
12.
Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies.
Clin Kidney J
; 17(3): sfae027, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500492
13.
18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study.
Expert Rev Hematol
; 17(1-3): 95-100, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299464
14.
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
J Clin Oncol
; 42(2): 205-217, 2024 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37874957
15.
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapy.
Bone Marrow Transplant
; 59(1): 93-100, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919456
16.
ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.
Blood
; 118(16): 4401-10, 2011 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21865343
17.
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement.
Haematologica
; 103(2): e92-e93, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242296
18.
Safety and tolerability of a 90-minute rapid infusion of Sandoz biosimilar rituximab in B-cell lymphoproliferative disorders in a real-world setting.
Clin Transl Sci
; 16(2): 305-312, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36385738
19.
Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma.
Immunotherapy
; 15(16): 1369-1374, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718888
20.
PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphoma.
EJHaem
; 4(4): 1081-1088, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38024636